Your browser doesn't support javascript.
loading
Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.
Huang, C-N; Huang, S-P; Pao, J-B; Hour, T-C; Chang, T-Y; Lan, Y-H; Lu, T-L; Lee, H-Z; Juang, S-H; Wu, P-P; Huang, C-Y; Hsieh, C-J; Bao, B-Y.
Affiliation
  • Huang CN; Department of Urology Cancer Center, Kaohsiung Medical University Hospital, Taiwan.
J Intern Med ; 271(5): 499-509, 2012 May.
Article in En | MEDLINE | ID: mdl-21880074

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / Receptors, Estrogen / Estrogens / Androgen Antagonists / Androgens Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2012 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / Receptors, Estrogen / Estrogens / Androgen Antagonists / Androgens Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2012 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom